Skip to main content
Signal8

Lazarus Howard

SEC insider (Form 3/4/5 filer). CIK 0002127626. Chief Medical Officer at Avalyn Pharma Inc. (AVLN). 1 reported Form 4/5 transaction since Sep 2024; latest on Apr 29, 2026. Located in BOSTON, MA.

Companies Lazarus Howard has filed insider reports for

  • Avalyn Pharma Inc. (AVLN): Officer, Chief Medical Officer
Lazarus Howard profile photo

Lazarus Howard

CIK: 0002127626

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)1 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Avalyn Pharma Inc. logo
AVLN

Avalyn Pharma Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (1 total)

  • Avalyn Pharma Inc. logo
    AVLN

    Avalyn Pharma Inc.

    Apr 29, 2026
    Award

    Stock Option (Right to Buy)

    Direct
    212K shares-

1-1 of 1